Dear colleagues, the final program of the XXXII Symposium on Bioinformatics and Computer-Aided Drug Discovery was finally composed by 16 October 2026.
Three types of reports will be presented at the Symposium:
Plenary lectures - 40 minutes per talk + 20 minutes for questions, answers, and discussions.
Keynote lectures - 20 minutes per talk + 10 minutes for questions, answers, and discussions.
Oral presentations - 15 minutes per talk + 5 minutes for questions, answers, and discussions.
Young Scientists flash presentations - 5 minutes per talk + 5 minutes for questions, answers, and discussions.
To provide the extended feasibilities of communication between the Symposium participants, E-Poster Session will be held on October 1-21, 2026. The posters are available only for the registered participants of the Symposium, after authorization.
Discussions between the participants will be arranged in private mode, by correspondence. The corresponding author’s email address can be found in the "Address for Correspondence" field.
The Organizing Committee asks the corresponding authors to answer on the questions of other Symposium’s participants as soon as possible.
Participants of the Young Scientists Contest may be also asked by the Members of the International Scientific Committee. Based on the responses, twelve young scientists will be selected for the Flash Presentations by October 8, 2026, and the best young scientists will be awarded by October 21, 2026.
The best posters will be awarded by the special Diplomas.
All reports will be presented in English.
Scheduled time - Moscow (UTC+3).
Wednesday October 21, 2026 |
|
Chairmans: Kunal Roy and Irina Panina |
|
| Keynote lectures | |
| 09:00 |
ATOMISTIC INSIGHTS INTO A LANTIBIOTIC’S MECHANISM: AN INTEGRATED MOLECULAR DYNAMICS AND BIOPHYSICAL STUDY
Research Institute for Systems Biology, Rospotrebnadzor, Moscow, Russia
|
| 09:30 |
DELTA: DATABASE FOR EXTENDED LIGAND-TARGET ANALYSES - A NEW BALANCED RESOURCE FOR AI APPLICATIONS IN DRUG DISCOVERY
Università degli Studi di Milano, Milano, Italy
|
| Oral presentations | |
|
BIOMARKER-GUIDED Q-RASAR MODELING OF ANTIBIOTICS-MICROPLASTICS MIXTURES: TOWARDS PREDICTIVE AQUATIC TOXICOLOGY AND RESISTANCE RISK ASSESSMENT Jadavpur University, Kolkata, India |
|
|
ADMETOX-AI: MULTI-TASK DEEP LEARNING PLATFORM FOR COMPREHENSIVE ADMET PROPERTY PREDICTION ADMETox.AI, Rostov-on-Don, Russia |
|
|
MULTIVARIATE QSAR MODELING FOR IDENTIFYING STRUCTURAL DRIVERS AND PRIORITIZING TOXIC CHEMICALS AFFECTING CRASSOSTREA VIRGINICA Jadavpur University, Kolkata, India |
|
| Keynote lectures | |
| 11:00 |
AI-BASED REDESIGN OF A PERTUSSIS TOXIN PT-A PROTEIN FOR A VACCINE USE
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia
|
| 11:30 |
METRICS FOR UNBIASED SELECTION OF MACHINE LEARNING REGRESSION MODELS
Jadavpur University, India
|
| Oral presentations | |
|
IMPROVING THE ACCURACY AND GENERALIZABILITY OF MOLECULAR PROPERTY REGRESSION MODELS WITH A SUBSTRUCTURE-SUBSTITUTION-RULE-INFORMED FRAMEWORK Tsinghua University, Beijing, China |
|
|
A WORKFLOW FOR BUILDING (Q)SAR MODELS WITH IMBALANCED AND HETEROGENEOUS DATA Institute of Biomedical Chemistry, Moscow, Russia |
|
|
ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY: FROM DRUG-TARGET INTERACTIONS AND SYNERGISTIC DRUG COMBINATIONS TO GENERATIVE MOLECULAR DESIGN Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran |
|
lunch break 13:00-16:00 |
|
Chairmans: Roman Zubarev and Dmitry Osolodkin |
|
| Keynote lectures | |
| 16:00 |
LIPOPHILICITY IN DRUG DESIGN: EVOLUTION FROM THE RULE OF FIVE TO AI-DRIVEN DISCOVERY
University of Costa Rica, San Pedro, San José, Costa Rica; National Advanced Computing Collaboratory (CNCA), National High Technology Center (CeNAT), Costa Rica
|
| 16:30 |
DATASET CONSTRAINTS: A CASE OF PHARMACOLOGICALLY STRATIFIED MULTI-TARGET QSAR BENCHMARK FOR OPIOID RECEPTOR FUNCTIONAL ACTIVITY
Division of Pharmaceutical Sciences, School of Pharmacy, University of Wyoming, United States
|
| 17:00 |
GRAND CHALLENGES FOR PREDICTIVE MODELING IN SMALL MOLECULE DRUG DISCOVERY
Psivant Therapeutics, Boston, MA, United States
|
| 17:30 |
WEB SERVICES FOR IN SILICO TOXICITY PREDICTION IN PRECLINICAL DRUG DEVELOPMENT
Institute of Biomedical Chemistry, Moscow, Russia
|
| Plenary lectures | |
| 18:00 |
DECRYPTING DRUG MECHANISM OF ACTION BY PROTEOMICS
Technical University of Munich, Freising, Germany
|
| 19:00 | Сlosure of the XXXII Symposium on Bioinformatics and Computer-Aided Drug Discovery |
The Local Organizing Committee of the BCADD-2026